Skip to main content
SpringerLink
Log in

Current Status and Growth of Peritoneal Dialysis

  • Living reference work entry
  • First Online:
Nolph and Gokal's Textbook of Peritoneal Dialysis

  • 73 Accesses

Abstract

The use of peritoneal dialysis (PD) in end-stage renal disease is a well-known renal replacement modality now. The interest in using PD for ESRD has been increasing over the last three decades. Due to its high cost and infrastructural benefits over hemodialysis (HD), PD is often used in developing countries, where cost and available sources constitute a significant issue. This chapter discusses (a) development of PD, (b) trends in different aspects of PD, and (c) advantages and disadvantages of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Kolff WJ. The artificial kidney. J Mt Sinai Hosp N Y. 1947;14(2):71–9.

    CAS  PubMed  Google Scholar 

  2. Maxwell MH, Rockney RE, Kleeman CR, Twiss MR. Peritoneal dialysis. 1. Technique and applications. J Am Med Assoc. 1959;170(8):917–24.

    CAS  PubMed  Google Scholar 

  3. Grollman A, Turner LB, Mc LJ. Intermittent peritoneal lavage in nephrectomized dogs and its application to the human being. AMA Arch Intern Med. 1951;87(3):379–90.

    CAS  PubMed  Google Scholar 

  4. Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Oreopoulos DG, Robson M, Izatt S, Clayton S, deVeber GA. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs. 1978;24:484–9.

    CAS  PubMed  Google Scholar 

  6. Twardowski ZJ. Peritoneal access: the past, present, and the future. Contrib Nephrol. 2006;150:195–201.

    PubMed  Google Scholar 

  7. Twardowski ZJ. History of peritoneal access development. Int J Artif Organs. 2006;29(1):2–40.

    PubMed  Google Scholar 

  8. Tenckhoff H, Curtis FK. Experience with maintenance peritoneal dialysis in the home. Trans Am Soc Artif Intern Organs. 1970;16:90–5.

    CAS  PubMed  Google Scholar 

  9. Lupo A, Tarchini R, Carcarini G, Catizone L, Cocchi R, De Vecchi A, et al. Long-term outcome in continuous ambulatory peritoneal dialysis: a 10-year-survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis. 1994;24(5):826–37.

    CAS  PubMed  Google Scholar 

  10. Negoi D, Prowant BF, Twardowski ZJ. Current trends in the use of peritoneal dialysis catheters. Adv Perit Dial. 2006;22:147–52.

    PubMed  Google Scholar 

  11. Gokal R, Alexander S, Ash S, Chen TW, Danielson A, Holmes C, et al. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. (Official report from the International Society for Peritoneal Dialysis). Perit Dial Int. 1998;18(1):11–33.

    Article  CAS  PubMed  Google Scholar 

  12. Warady BA, Sullivan EK, Alexander SR. Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int Suppl. 1996;53:S68–71.

    CAS  PubMed  Google Scholar 

  13. Honda M, Iitaka K, Kawaguchi H, Hoshii S, Akashi S, Kohsaka T, et al. The Japanese National Registry data on pediatric CAPD patients: a ten-year experience. A report of the Study Group of Pediatric PD Conference. Perit Dial Int. 1996;16(3):269–75.

    Article  CAS  PubMed  Google Scholar 

  14. Favazza A, Petri R, Montanaro D, Boscutti G, Bresadola F, Mioni G. Insertion of a straight peritoneal catheter in an arcuate subcutaneous tunnel by a tunneler: long-term experience. Perit Dial Int. 1995;15(8):357–62.

    Article  CAS  PubMed  Google Scholar 

  15. Stephen RL, Atkin-Thor E, Kolff WJ. Recirculating peritoneal dialysis with subcutaneous catheter. Trans Am Soc Artif Intern Organs. 1976;22:575–85.

    CAS  PubMed  Google Scholar 

  16. Gotloib L, Galili N, Nisencorn I, Servadio C, Garmizo AL, Sudarsky M. Subcutaneous intraperitoneal prosthesis for maintenance peritoneal dialysis. Lancet. 1975;1(7920):1318–9.

    Article  CAS  PubMed  Google Scholar 

  17. Twardowski ZJ, Anderson PC. Continuous ambulatory peritoneal dialysis for psoriasis. Mo Med. 1985;82(1):15–7.

    CAS  PubMed  Google Scholar 

  18. Twardowski ZJ, Prowant BF, Khanna R, Nichols WK, Nolph KD. Long-term experience with Swan Neck Missouri catheters. ASAIO Trans. 1990;36(3):M491–4.

    CAS  PubMed  Google Scholar 

  19. Yerram P, Gill A, Prowant B, Saab G, Misra M, Whaley-Connell A. A 9-year survival analysis of the presternal Missouri swan-neck catheter. Adv Perit Dial. 2007;23:90–3.

    PubMed  Google Scholar 

  20. Golper TA, Brier ME, Bunke M, Schreiber MJ, Bartlett DK, Hamilton RW, et al. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis. 1996;28(3):428–36.

    Article  CAS  PubMed  Google Scholar 

  21. Buoncristiani U, Bianchi P, Cozzari M, Carobi C, Quintaliani G, Barbarossa D. A new safe simple connection system for CAPD. Nephrol Urol Androl. 1980;1:45–50.

    Google Scholar 

  22. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet. 1983;2(8351):642–4.

    Article  CAS  PubMed  Google Scholar 

  23. Churchil ON, Taylor OW, Vas SI, Oreopoulos OG, Bettcher KB, Fenton SSA, Fine A, Lavoie S, Page O, Wu G, Beecroft ML, Pemberton R, Wilczynski NL, Deveber GA, Williams W. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group. Perit Dial Int. 1989;9(3):159–63.

    Article  Google Scholar 

  24. Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int. 1992;42(4):967–74.

    Article  CAS  PubMed  Google Scholar 

  25. Harris DC, Yuill EJ, Byth K, Chapman JR, Hunt C. Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7(11):2392–8.

    CAS  PubMed  Google Scholar 

  26. Nolph KD. Has peritoneal dialysis peaked? The impact of the CANUSA study. The Canadian-USA Multicenter study. ASAIO J. 1996;42(3):136–8.

    CAS  PubMed  Google Scholar 

  27. Oreopoulos D, Thodis E. The history of peritoneal dialysis: early years at Toronto Western Hospital. Dial Transplant. 2010;39:338–42.

    Article  Google Scholar 

  28. Odel HM, Ferris DO, Power MH. Peritoneal lavage as an effective means of extrarenal excretion; a clinical appraisal. Am J Med. 1950;9(1):63–77.

    Article  CAS  PubMed  Google Scholar 

  29. Twiss MR, Maxwell MH. Peritoneal dialysis. Am J Nurs. 1959;59:1560–3.

    CAS  PubMed  Google Scholar 

  30. McIntyre CW. Update on peritoneal dialysis solutions. Kidney Int. 2007;71(6):486–90.

    Article  CAS  PubMed  Google Scholar 

  31. Krediet RT, Zweers MM, van der Wal AC, Struijk DG. Neoangiogenesis in the peritoneal membrane. Perit Dial Int. 2000;20(Suppl 2):S19–25.

    Article  PubMed  Google Scholar 

  32. Krediet RT, Van Esch S, Smit W, Michels WM, Zweers MM, Ho-Dac-Pannekeet MM, et al. Peritoneal membrane failure in peritoneal dialysis patients. Blood Purif. 2002;20(5):489–93.

    Article  PubMed  Google Scholar 

  33. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004;66(1):408–18.

    Article  PubMed  Google Scholar 

  34. Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int. 2005;25(3):248–55.

    Article  PubMed  Google Scholar 

  35. Mistry CD. The beginning of icodextrin. Perit Dial Int. 2011;31(Suppl 2):S49–52.

    Article  PubMed  Google Scholar 

  36. Shockley TR, Wang T, Lindholm B. Future clinical research with icodextrin-containing solutions. Perit Dial Int. 1997;17(Suppl 2):S70–4.

    Article  PubMed  Google Scholar 

  37. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int. 1994;46(2):496–503.

    Article  CAS  PubMed  Google Scholar 

  38. Chang TI, Ryu DR, Yoo TH, Kim HJ, Kang EW, Kim H, et al. Effect of icodextrin solution on the preservation of residual renal function in peritoneal dialysis patients: a randomized controlled study. Medicine (Baltimore). 2016;95(13):e2991.

    Article  CAS  Google Scholar 

  39. Posthuma N, ter Wee PM, Donker AJ, Oe PL, van Dorp W, Peers EM, et al. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. Perit Dial Int. 1997;17(6):602–7.

    Article  CAS  PubMed  Google Scholar 

  40. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant. 1997;12(3):550–3.

    CAS  PubMed  Google Scholar 

  41. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis. 2002;39(4):862–71.

    Article  CAS  PubMed  Google Scholar 

  42. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol. 2005;16(2):546–54.

    Article  CAS  PubMed  Google Scholar 

  43. Lee SH, Park HC, Sim SR, Chung SJ, Kim KJ, Park WI, et al. Severe cutaneous hypersensitivity to icodextrin in a continuous ambulatory peritoneal dialysis patient. J Nephrol. 2006;19(5):673–6.

    CAS  PubMed  Google Scholar 

  44. Frampton JE, Plosker GL. Icodextrin: a review of its use in peritoneal dialysis. Drugs. 2003;63(19):2079–105.

    Article  CAS  PubMed  Google Scholar 

  45. Opatrna S, Racek J, Stehlik P, Senft V, Sefrna F, Topolcan O, et al. Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis. Cas Lek Cesk. 2002;141(9):281–5.

    CAS  PubMed  Google Scholar 

  46. Haag-Weber M. Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis. Wien Klin Wochenschr. 2005;117(Suppl 6):89–97.

    Article  PubMed  Google Scholar 

  47. Alam M, Krause M. Peritoneal dialysis solutions UpToDate2008. Updated May 2019. Available from: https://www.uptodate.com/contents/peritoneal-dialysis-solutions?search=peritoneal%20dialysis%20solutions&source=search_result&selectedTitle=2~57&usage_type=default&display_rank=1.

  48. Jones MR, Gehr TW, Burkart JM, Hamburger RJ, Kraus AP Jr, Piraino BM, et al. Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int. 1998;18(2):210–6.

    Article  CAS  PubMed  Google Scholar 

  49. Kopple JD, Bernard D, Messana J, Swartz R, Bergstrom J, Lindholm B, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47(4):1148–57.

    Article  CAS  PubMed  Google Scholar 

  50. Zareie M, Tangelder GJ, ter Wee PM, Hekking LH, van Lambalgen AA, Keuning ED, et al. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD. Nephrol Dial Transplant. 2005;20(12):2783–92.

    CAS  PubMed  Google Scholar 

  51. Zareie M, van Lambalgen AA, ter Wee PM, Hekking LH, Keuning ED, Schadee-Eestermans IL, et al. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid. Perit Dial Int. 2005;25(1):58–67.

    CAS  PubMed  Google Scholar 

  52. Chang JM, Lin SP, Lai YH, Chen HC. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells. Am J Nephrol. 2007;27(2):206–11.

    PubMed  Google Scholar 

  53. Bazzato G, Coli U, Landini S, Fracasso A, Morachiello P, Righetto F, et al. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients? Trans Am Soc Artif Intern Organs. 1982;28:280–6.

    CAS  PubMed  Google Scholar 

  54. Himmele R, Jensen L, Fenn D, Ho CH, Sawin DA, Diaz-Buxo JA. A new neutral-pH low-GDP peritoneal dialysis fluid. Perit Dial Int. 2012;32(4):444–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Lobbedez T, Moldovan R, Lecame M. Hurault de Ligny B, El Haggan W, Ryckelynck JP. Assisted peritoneal dialysis. Experience in a French renal department. Perit Dial Int. 2006;26(6):671–6.

    PubMed  Google Scholar 

  56. Povlsen JV, Ivarsen P. Assisted automated peritoneal dialysis (AAPD) for the functionally dependent and elderly patient. Perit Dial Int. 2005;25(Suppl 3):S60–3.

    PubMed  Google Scholar 

  57. de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, et al. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med. 1994;120(4):264–71.

    PubMed  Google Scholar 

  58. Bro S, Bjorner JB, Tofte-Jensen P, Klem S, Almtoft B, Danielsen H, et al. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int. 1999;19(6):526–33.

    CAS  PubMed  Google Scholar 

  59. Dell’Aquila R, Berlingo G, Pellanda MV, Contestabile A. Continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: are there differences in outcome? Contrib Nephrol. 2009;163:292–9.

    PubMed  Google Scholar 

  60. Perez-Fontan M, Rodriguez-Carmona A. Peritoneal catheter removal for severe peritonitis: landscape after a lost battle. Perit Dial Int. 2007;27(2):155–8.

    PubMed  Google Scholar 

  61. Verger C, Duman M, Durand PY, Veniez G, Fabre E, Ryckelynck JP. Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients. An analysis of data from the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant. 2007;22(4):1218–23.

    PubMed  Google Scholar 

  62. Oliver MJ, Quinn RR, Richardson EP, Kiss AJ, Lamping DL, Manns BJ. Home care assistance and the utilization of peritoneal dialysis. Kidney Int. 2007;71(7):673–8.

    CAS  PubMed  Google Scholar 

  63. Boyer A, Lanot A, Lambie M, Guillouet S, Lobbedez T, Béchade C. Trends in assisted peritoneal dialysis over the last decade: a cohort study from the French Peritoneal Dialysis Registry. Clin Kidney J. 2020;13(6):1003–1011. https://doi.org/10.1093/ckj/sfaa051. PMID: 33391743; PMCID: PMC7769513.

  64. Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant. 2013;28(10):2553–69.

    PubMed  Google Scholar 

  65. Annual Baxter World-Wide Survey: Baxter Healthcare Corporation; 1998. Available from: http://www.annualreports.com/HostedData/AnnualReportArchive/b/NYSE_BAX_1998.pdf

  66. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20(12):2587–93.

    PubMed  Google Scholar 

  67. Collins AJ, Foley RN, Gilbertson DT, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015;5(1):2–7.

    Google Scholar 

  68. Ahmed FA, Catic AG. Decision-Making in Geriatric Patients with End-Stage Renal Disease: Thinking Beyond Nephrology. J Clin Med. 2018;8(1):5. https://doi.org/10.3390/jcm8010005. PMID: 30577486; PMCID: PMC6352025.

  69. Blake PG. Adequacy of dialysis revisited. Kidney Int. 2003;63(4):1587–99.

    PubMed  Google Scholar 

  70. Gokal R, Blake PG, Passlick-Deetjen J, Schaub TP, Prichard S, Burkart JM. What is the evidence that peritoneal dialysis is underutilized as an ESRD therapy? Semin Dial. 2002;15(3):149–61.

    PubMed  Google Scholar 

  71. Nissenson AR, Prichard SS, Cheng IK, Gokal R, Kubota M, Maiorca R, et al. ESRD modality selection into the 21st century: the importance of non medical factors. ASAIO J. 1997;43(3):143–50.

    CAS  PubMed  Google Scholar 

  72. Mignon F, Michel C, Viron B. Why so much disparity of PD in Europe? Nephrol Dial Transplant. 1998;13(5):1114–7.

    CAS  PubMed  Google Scholar 

  73. Perry D, Schatzke D, Royer R, Hackman D, Dasgupta MK. Rapid growth in the use of automated peritoneal dialysis (APD) in adult patients on peritoneal dialysis. Adv Perit Dial. 1998;14:57–9.

    CAS  PubMed  Google Scholar 

  74. Correa-Rotter R. APD in the developing world: is there a future? Semin Dial. 2002;15(6):385–7.

    PubMed  Google Scholar 

  75. Negoi D, Nolph KD. Automated peritoneal dialysis – indications and management. Contrib Nephrol. 2006;150:278–84.

    PubMed  Google Scholar 

  76. Ronnholm KA, Holmberg C. Peritoneal dialysis in infants. Pediatr Nephrol. 2006;21(6):751–6.

    PubMed  Google Scholar 

  77. Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT. Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int. 1999;56(2):720–8.

    CAS  PubMed  Google Scholar 

  78. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant. 1999;14(5):1163–70.

    CAS  PubMed  Google Scholar 

  79. Prichard SS. Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int. 1996;16(1):69–72.

    CAS  PubMed  Google Scholar 

  80. Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenson A. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int. 2005;68(1):378–90.

    PubMed  Google Scholar 

  81. Aziz F, Chaudhary K. Peritoneal dialysis in patients with abdominal surgeries and abdominal complications. Adv Perit Dial. 2017;33(2017):40–6.

    PubMed  Google Scholar 

  82. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW, Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis. 2004;43(5):891–9.

    PubMed  Google Scholar 

  83. Lameire N, Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist – a European survey. Nephrol Dial Transplant. 1999;14(Suppl 6):16–23.

    PubMed  Google Scholar 

  84. Diaz-Buxo JA. Early referral and selection of peritoneal dialysis as a treatment modality. Nephrol Dial Transplant. 2000;15(2):147–9.

    CAS  PubMed  Google Scholar 

  85. Piccoli GB, Mezza E, Burdese M, Consiglio V, Vaggione S, Mastella C, et al. Dialysis choice in the context of an early referral policy: there is room for self care. J Nephrol. 2005;18(3):267–75.

    PubMed  Google Scholar 

  86. Golper T. Patient education: can it maximize the success of therapy? Nephrol Dial Transplant. 2001;16(Suppl 7):20–4.

    PubMed  Google Scholar 

  87. Manns BJ, Taub K, Vanderstraeten C, Jones H, Mills C, Visser M, et al. The impact of education on chronic kidney disease patients’ plans to initiate dialysis with self-care dialysis: a randomized trial. Kidney Int. 2005;68(4):1777–83.

    PubMed  Google Scholar 

  88. Nissenson AR, Prichard SS, Cheng IK, Gokal R, Kubota M, Maiorca R, et al. Non-medical factors that impact on ESRD modality selection. Kidney Int Suppl. 1993;40:S120–7.

    CAS  PubMed  Google Scholar 

  89. Van Biesen W, Wiedemann M, Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol. 1998;9(12 Suppl):S55–62.

    PubMed  Google Scholar 

  90. Horl WH, de Alvaro F, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies – an international review: access to ESRD treatments. Nephrol Dial Transplant. 1999;14(Suppl 6):10–5.

    PubMed  Google Scholar 

  91. Li PK, Chow KM. The cost barrier to peritoneal dialysis in the developing world – an Asian perspective. Perit Dial Int. 2001;21(Suppl 3):S307–13.

    PubMed  Google Scholar 

  92. Mendelssohn DC, Langlois N, Blake PG. Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology. Perit Dial Int. 2004;24(6):531–7.

    PubMed  Google Scholar 

  93. Mettang T. Changes in dialysis reimbursement regulations in Germany. Perit Dial Int. 2004;24(6):526–7.

    PubMed  Google Scholar 

  94. Maiorca R, Vonesh E, Cancarini GC, Cantaluppi A, Manili L, Brunori G, et al. A six-year comparison of patient and technique survivals in CAPD and HD. Kidney Int. 1988;34(4):518–24.

    CAS  PubMed  Google Scholar 

  95. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int. 1994;45(4):1163–9.

    CAS  PubMed  Google Scholar 

  96. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6(2):184–91.

    CAS  PubMed  Google Scholar 

  97. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6(2):177–83.

    CAS  PubMed  Google Scholar 

  98. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30(3):334–42.

    CAS  PubMed  Google Scholar 

  99. Foley RN, Parfrey PS, Harnett JD, Kent GM, O’Dea R, Murray DC, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9(2):267–76.

    CAS  PubMed  Google Scholar 

  100. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999;34(6):1065–74.

    Article  CAS  PubMed  Google Scholar 

  101. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT, et al. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol. 2003;14(11):2851–60.

    Article  PubMed  Google Scholar 

  102. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med. 2005;143(3):174–83.

    Article  PubMed  Google Scholar 

  103. van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, et al. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant. 2016;31(1):120–8.

    Article  PubMed  Google Scholar 

  104. Wang IK, Lin CL, Yen TH, Lin SY, Sung FC. Comparison of survival between hemodialysis and peritoneal dialysis patients with end-stage renal disease in the era of icodextrin treatment. Eur J Intern Med. 2018;50:69–74.

    Article  CAS  PubMed  Google Scholar 

  105. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl. 2006;103:S3–11.

    Article  Google Scholar 

  106. Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci. 2010;339(5):453–6.

    Article  PubMed  Google Scholar 

  107. Krediet RT. Preservation of residual kidney function and urine volume in patients on dialysis. Clin J Am Soc Nephrol. 2017;12(3):377–9.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Lee MJ, Park JT, Park KS, Kwon YE, Oh HJ, Yoo TH, et al. Prognostic value of residual urine volume, GFR by 24-hour urine collection, and eGFR in patients receiving dialysis. Clin J Am Soc Nephrol. 2017;12(3):426–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Marron B, Remon C, Perez-Fontan M, Quiros P, Ortiz A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int Suppl. 2008;108:S42–51.

    Article  Google Scholar 

  110. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, et al. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc. 1983;19:397–403.

    CAS  PubMed  Google Scholar 

  111. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans. 1991;37(4):598–604.

    CAS  PubMed  Google Scholar 

  112. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556–64.

    CAS  PubMed  Google Scholar 

  113. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62(3):1046–53.

    Article  PubMed  Google Scholar 

  114. Chandna SM, Farrington K. Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial. 2004;17(3):196–201.

    Article  PubMed  Google Scholar 

  115. van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7(5):745–50.

    PubMed  Google Scholar 

  116. Caravaca F, Arrobas M, Pizarro JL, Sanchez-Casado E. Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients. Nephrol Dial Transplant. 2001;16(4):776–82.

    Article  CAS  PubMed  Google Scholar 

  117. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med. 2003;139(2):105–12.

    Article  CAS  PubMed  Google Scholar 

  118. Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 2001;59(3):1128–33.

    Article  CAS  PubMed  Google Scholar 

  119. Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematu T. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int Suppl. 1997;62:S105–7.

    CAS  PubMed  Google Scholar 

  120. Kim GC, Vonesh EF, Korbet SM. The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2002;22(1):53–9.

    Article  PubMed  Google Scholar 

  121. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 2003;64(6):2222–8.

    Article  PubMed  Google Scholar 

  122. Geerlings W, Tufveson G, Brunner FP, Ehrich JH, Fassbinder W, Landais P, et al. Combined report on regular dialysis and transplantation in Europe, XXI, 1990. Nephrol Dial Transplant. 1991;6(Suppl 4):5–29.

    PubMed  Google Scholar 

  123. Shen JI, Mitani AA, Saxena AB, Goldstein BA, Winkelmayer WC. Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013;33(2):155–66.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Jindal KK, Hirsch DJ. Excellent technique survival on home peritoneal dialysis: results of a regional program. Perit Dial Int. 1994;14(4):324–6.

    Article  CAS  PubMed  Google Scholar 

  125. Bistrup C, Holm-Nielsen A, Pedersen RS. Technique survival and complication rates in a newly started CAPD center (five years of experience). Perit Dial Int. 1996;16(1):90–1.

    Article  CAS  PubMed  Google Scholar 

  126. Kolesnyk I, Dekker FW, Boeschoten EW, Krediet RT. Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int. 2010;30(2):170–7.

    Article  PubMed  Google Scholar 

  127. Burkart JM. Significance, epidemiology, and prevention of peritoneal dialysis catheter infections. Perit Dial Int. 1996;16(Suppl 1):S340–6.

    Article  PubMed  Google Scholar 

  128. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int. 1997;17(4):360–4.

    Article  CAS  PubMed  Google Scholar 

  129. Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Pediatr Nephrol. 2008;23(5):695–703.

    Article  PubMed  Google Scholar 

  130. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–9.

    PubMed  Google Scholar 

  131. Coester AM, Smit W, Struijk DG, Parikova A, Krediet RT. Longitudinal analysis of peritoneal fluid transport and its determinants in a cohort of incident peritoneal dialysis patients. Perit Dial Int. 2014;34(2):195–203.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Wilkie ME, Plant MJ, Edwards L, Brown CB. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int. 1997;17(1):84–7.

    Article  CAS  PubMed  Google Scholar 

  133. Takatori Y, Akagi S, Sugiyama H, Inoue J, Kojo S, Morinaga H, et al. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial. Clin J Am Soc Nephrol. 2011;6(6):1337–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Silver SA, Harel Z, Perl J. Practical considerations when prescribing icodextrin: a narrative review. Am J Nephrol. 2014;39(6):515–27.

    Article  CAS  PubMed  Google Scholar 

  135. Twardowski ZJ, Nolph KD. Peritoneal dialysis: how much is enough? Semin Dial. 1988;1:75.

    Article  Google Scholar 

  136. Teehan BP, Schleifer CR, Sigler MH, Gilgore GS, et al. A quantitative approach to the CAPD prescription. Perit Dial Bull. 1985;5:152–6.

    Article  Google Scholar 

  137. Blake PG, Sombolos K, Abraham G, Weissgarten J, Pemberton R, Chu GL, et al. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int. 1991;39(4):700–6.

    Article  CAS  PubMed  Google Scholar 

  138. Lameire NH, Vanholder R, Veyt D, Lambert MC, Ringoir S. A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int. 1992;42(2):426–32.

    Article  CAS  PubMed  Google Scholar 

  139. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int Suppl. 1993;40:S4–15.

    CAS  PubMed  Google Scholar 

  140. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198–207.

    Google Scholar 

  141. Di Giulio S, Meschini L, Triolo G. Dialysis outcome quality initiative (DOQI) guideline for hemodialysis adequacy. Int J Artif Organs. 1998;21(11):757–61.

    Article  PubMed  Google Scholar 

  142. Bargman JM, Thorpe KE, Churchill DN, Group CPDS. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158–62.

    CAS  PubMed  Google Scholar 

  143. Bhaskaran S, Schaubel DE, Jassal SV, Thodis E, Singhal MK, Bargman JM, et al. The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int. 2000;20(2):181–7.

    Article  CAS  PubMed  Google Scholar 

  144. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Wang AY, et al. Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2001;12(2):355–60.

    CAS  PubMed  Google Scholar 

  145. Jansen MA, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT, et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int. 2005;68(3):1199–205.

    Article  PubMed  Google Scholar 

  146. Lo WK, Lui SL, Chan TM, Li FK, Lam MF, Tse KC, et al. Minimal and optimal peritoneal Kt/V targets: results of an anuric peritoneal dialysis patient’s survival analysis. Kidney Int. 2005;67(5):2032–8.

    Article  PubMed  Google Scholar 

  147. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–20.

    CAS  PubMed  Google Scholar 

  148. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64(2):649–56.

    Article  PubMed  Google Scholar 

  149. Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26(5):520–2.

    Article  PubMed  Google Scholar 

  150. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis. 1991;17(4):462–71.

    Article  CAS  PubMed  Google Scholar 

  151. Cianciaruso B, Brunori G, Kopple JD, Traverso G, Panarello G, Enia G, et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis. 1995;26(3):475–86.

    Article  CAS  PubMed  Google Scholar 

  152. Jadeja YP, Kher V. Protein energy wasting in chronic kidney disease: an update with focus on nutritional interventions to improve outcomes. Indian J Endocrinol Metab. 2012;16(2):246–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Mehrotra R, Kopple JD. Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis. Adv Ren Replace Ther. 2003;10(3):194–212.

    Article  PubMed  Google Scholar 

  154. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15(7):953–60.

    Article  CAS  PubMed  Google Scholar 

  155. Kaysen GA. Association between inflammation and malnutrition as risk factors of cardiovascular disease. Blood Purif. 2006;24(1):51–5.

    Article  PubMed  Google Scholar 

  156. Guedes AM. Peritoneal protein loss, leakage or clearance in peritoneal dialysis, where do we stand? Perit Dial Int. 2019;39(3):201–9.

    Article  PubMed  Google Scholar 

  157. Dombros N, Dratwa M, Feriani M, Gokal R, Heimburger O, Krediet R, et al. European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. Nephrol Dial Transplant. 2005;20(Suppl 9):ix8–ix12.

    PubMed  Google Scholar 

  158. Westra WM, Kopple JD, Krediet RT, Appell M, Mehrotra R. Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients. Perit Dial Int. 2007;27(2):192–5.

    Article  PubMed  Google Scholar 

  159. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, et al. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2001;12(11):2450–7.

    CAS  PubMed  Google Scholar 

  160. Bergstrom J. Why are dialysis patients malnourished? Am J Kidney Dis. 1995;26(1):229–41.

    Article  CAS  PubMed  Google Scholar 

  161. Caravaca F, Arrobas M, Dominguez C. Influence of residual renal function on dietary protein and caloric intake in patients on incremental peritoneal dialysis. Perit Dial Int. 1999;19(4):350–6.

    Article  CAS  PubMed  Google Scholar 

  162. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN. How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl. 1996;56:S56–61.

    CAS  PubMed  Google Scholar 

  163. Soleymanian T, Ghods A. The deleterious effect of metabolic acidosis on nutritional status of hemodialysis patients. Saudi J Kidney Dis Transpl. 2011;22(6):1149–54.

    PubMed  Google Scholar 

  164. de Oliveira CM, Vidal CL, Cristino EF, Pinheiro FM Jr, Kubrusly M. Metabolic acidosis and its association with nutritional status in hemodialysis. J Bras Nefrol. 2015;37(4):458–66.

    PubMed  Google Scholar 

  165. Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial. 2004;17(6):455–65.

    Article  PubMed  Google Scholar 

  166. Stein A, Moorhouse J, Iles-Smith H, Baker F, Johnstone J, James G, et al. Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int. 1997;52(4):1089–95.

    Article  CAS  PubMed  Google Scholar 

  167. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003;14(8):2119–26.

    Article  CAS  PubMed  Google Scholar 

  168. Tjiong HL, van den Berg JW, Wattimena JL, Rietveld T, van Dijk LJ, van der Wiel AM, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol. 2005;16(5):1486–93.

    Article  CAS  PubMed  Google Scholar 

  169. Brown M, Burrows L, Pruett T, Burrows T. Hemodialysis-induced myocardial stunning: a review. Nephrol Nurs J. 2015;42(1):59–66. quiz 7

    PubMed  Google Scholar 

  170. Faller B, Lameire N. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant. 1994;9(3):280–6.

    CAS  PubMed  Google Scholar 

  171. Bouma SF, Dwyer JT. Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis. J Am Diet Assoc. 1984;84(2):194–7.

    CAS  PubMed  Google Scholar 

  172. Tzamaloukas AH, Murata GH. Obesity and patient survival in chronic dialysis. Adv Perit Dial. 2004;20:79–85.

    PubMed  Google Scholar 

  173. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int. 2004;65(2):597–605.

    Article  PubMed  Google Scholar 

  174. Stack AG, Murthy BV, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int. 2004;65(6):2398–408.

    Article  PubMed  Google Scholar 

  175. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol. 2003;14(11):2894–901.

    PubMed  Google Scholar 

  176. McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int. 2004;24(4):340–6.

    PubMed  Google Scholar 

  177. Dasgupta I, Burden R. Blood pressure control before and after starting dialysis. Nephron Clin Pract. 2005;99(3):c86–91.

    PubMed  Google Scholar 

  178. Lameire N, Vanholder RC, Van Loo A, Lambert MC, Vijt D, Van Bockstaele L, et al. Cardiovascular diseases in peritoneal dialysis patients: the size of the problem. Kidney Int Suppl. 1996;56:S28–36.

    CAS  PubMed  Google Scholar 

  179. Wang IK, Lu CY, Lin CL, Liang CC, Yen TH, Liu YL, et al. Comparison of the risk of de novo cardiovascular disease between hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Int J Cardiol. 2016;218:219–24.

    PubMed  Google Scholar 

  180. Konings CJ, Kooman JP, van der Sande FM, Leunissen KM. Fluid status in peritoneal dialysis: what’s new? Perit Dial Int. 2003;23(3):284–90.

    PubMed  Google Scholar 

  181. Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol. 2004;15(8):2186–94.

    CAS  PubMed  Google Scholar 

  182. Zoccali C, Tripepi G, Mallamaci F. Predictors of cardiovascular death in ESRD. Semin Nephrol. 2005;25(6):358–62.

    PubMed  Google Scholar 

  183. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int. 2006;70(1):26–33.

    CAS  PubMed  Google Scholar 

  184. Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt KU, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(Suppl 2):ii1–47.

    PubMed  Google Scholar 

  185. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28(1):53–61.

    CAS  PubMed  Google Scholar 

  186. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584–90.

    CAS  PubMed  Google Scholar 

  187. Volkova N, Arab L. Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients. Am J Kidney Dis. 2006;47(1):24–36.

    PubMed  Google Scholar 

  188. Weber J, Mettang T, Hubel E, Kiefer T, Kuhlmann U. Survival of 138 surgically placed straight double-cuff Tenckhoff catheters in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1993;13(3):224–7.

    CAS  PubMed  Google Scholar 

  189. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol. 1998;9(10):1956–64.

    CAS  PubMed  Google Scholar 

  190. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–31.

    PubMed  Google Scholar 

  191. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol. 2005;16(2):539–45.

    CAS  PubMed  Google Scholar 

  192. Boeschoten EW, Ter Wee PM, Divino J. Peritoneal dialysis-related infections recommendations 2005 – an important tool for quality improvement. Nephrol Dial Transplant. 2006;21(Suppl 2):ii31–3.

    PubMed  Google Scholar 

  193. Cnossen TT, Konings CJ, Kooman JP, Lindholm B. Peritoneal sclerosis – aetiology, diagnosis, treatment and prevention. Nephrol Dial Transplant. 2006;21(Suppl 2):ii38–41.

    CAS  PubMed  Google Scholar 

  194. Chin AI, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis. 2006;47(4):697–712.

    PubMed  Google Scholar 

  195. Korte MR, Sampimon DE, Betjes MG, Krediet RT. Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol. 2011;7(9):528–38.

    CAS  PubMed  Google Scholar 

  196. Barreto DL, Sampimon DE, Struijk DG, Krediet RT. Early detection of imminent encapsulating peritoneal sclerosis: free water transport, selected effluent proteins, or both? Perit Dial Int. 2019;39(1):83–9.

    PubMed  Google Scholar 

  197. Wong CF. Clinical experience with tamoxifen in encapsulating peritoneal sclerosis. Perit Dial Int. 2006;26(2):183–4.

    PubMed  Google Scholar 

  198. Summers AM, Brenchley PE. An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now. Perit Dial Int. 2006;26(5):559–63.

    PubMed  Google Scholar 

  199. Julian-Mauro JC, Cuervo J, Rebollo P, Callejo D. Employment status and indirect costs in patients with renal failure: differences between different modalities of renal replacement therapy. Nefrologia. 2013;33(3):333–41.

    PubMed  Google Scholar 

  200. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA. 2004;291(6):697–703.

    CAS  PubMed  Google Scholar 

  201. de Fijter CWH, van Diepen ATN, Amiri F, Dekker FW, Krediet RT. Patient-reported outcomes (PROs) argue against the limited use of peritoneal dialysis in end-stage renal disease. Clin Nephrol. 2018;90(2):94–101.

    Article  PubMed  Google Scholar 

  202. Brown EA. Peritoneal dialysis for older people: overcoming the barriers. Kidney Int Suppl. 2008;108:S68–71.

    Google Scholar 

  203. Just PM, de Charro FT, Tschosik EA, Noe LL, Bhattacharyya SK, Riella MC. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant. 2008;23(7):2365–73.

    Article  PubMed  PubMed Central  Google Scholar 

  204. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611–22.

    Article  PubMed  Google Scholar 

  205. Chui BK, Manns B, Pannu N, Dong J, Wiebe N, Jindal K, et al. Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am J Kidney Dis. 2013;61(1):104–11.

    PubMed  Google Scholar 

  206. Duong U, Kalantar-Zadeh K, Molnar MZ, Zaritsky JJ, Teitelbaum I, Kovesdy CP, et al. Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients. Am J Nephrol. 2012;35(2):198–208.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of Wisconsin, Madison, WI, USA

    Fahad Aziz

  2. Division of Nephrology, University of Missouri, Columbia, MO, USA

    Ramesh Khanna

Authors
  1. Fahad Aziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ramesh Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fahad Aziz .

Editor information

Editors and Affiliations

  1. Nephrology, School of Medicine Department of Medicine Division of, Columbia, MO, USA

    Ramesh Khanna

  2. Dept. Medicine Div. Nephrology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands

    Raymond T. Krediet

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Aziz, F., Khanna, R. (2021). Current Status and Growth of Peritoneal Dialysis. In: Khanna, R., Krediet, R.T. (eds) Nolph and Gokal's Textbook of Peritoneal Dialysis. Springer, Cham. https://doi.org/10.1007/978-3-319-90760-4_41-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90760-4_41-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90760-4

  • Online ISBN: 978-3-319-90760-4

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation